Sanofi Pasteur
Sanofi in $155m influenza vaccine deal
February 12, 2018Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
Sanofi Pasteur Korea appoint new General Manager
July 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …
Sanofi to pay $20m fine for overcharging US veterans
April 4, 2017Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US
Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
Sanofi launches dengue immunisation program in Brazil
August 15, 2016Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines
Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
Sanofi Pasteur and MSD end European vaccines partnership
March 8, 2016Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines
Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
CHMP recommends Sanofi’s two-dose schedule HPV vaccine
March 3, 2016Research and Development HPV vaccine, MSD, Sanofi Pasteur
Sanofi Pasteur’s and MSD’s vaccine against human papillomavirus (HPV), Gardasil 9, has received a positive opinion from the European Medicine …
Sanofi Pasteur launches Zika vaccine R&D
February 2, 2016Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus
Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
Sanofi Pasteur to join the Human Vaccines Project
January 15, 2016Medical Communications, Research and Development Human Vaccines Project, Sanofi Pasteur, vaccines
Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …
Sanofi Pasteur ‘actively exploring’ universal flu vaccine
November 10, 2015Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine
Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …
David Khougazian announced as president of Sanofi Pasteur MSD
July 29, 2015Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur
Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …
Sanofi affiliate to supply 37 million vaccines
March 17, 2015Manufacturing and Production, Sales and Marketing GAVI, Sanofi, Sanofi Pasteur, Shantha Biotechnics, shan5, vaccines
Sanofi’s vaccines division Sanofi Pasteur has confirmed its affiliate Shantha Biotechnics in India has delivered the first 400,000 doses of …
Sanofi starts C. diff study
October 28, 2013Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium
Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …
Setback for Sanofi dengue vaccine
September 13, 2012Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine
Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …
Pharma manufacturing news in brief
August 14, 2012Manufacturing and Production Advanced Bioscience, Almac, Amneal, Cipla, Isis, Sanofi Pasteur
Cipla opening three new API plants as Indian trade delegations forges closer ties with Sri Lanka; plus facility updates from …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
